015: Subtype Specific Stratification and Targeting of Pancreatic Adenocarcinoma
HIPO Investigator:
Prof. Andreas Trummp
Dr. Martin Sprick
Prof. Roland Eils
Prof. Wilko Weichert
Dr. Jens Werner
Supported by: HIPO/POP
Entity: Pancreatic Adenocarcinoma (PDAC)
Publications:
Noll EM et al.; CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma, Nat. Med. 2016
Espinet E et al.; Cellular deconvolution and expression analysis of Stromal and Epithelial cells directly isolated from human Pancreatic Ductal Adenocarcinoma (PDAC); Pancreatology 2017